Biogen Inc Stock Total Debt

BIIB Stock  USD 216.34  4.32  2.04%   
Biogen Inc fundamentals help investors to digest information that contributes to Biogen's financial success or failures. It also enables traders to predict the movement of Biogen Stock. The fundamental analysis module provides a way to measure Biogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biogen stock.
The current year's Total Debt To Capitalization is expected to grow to 0.35.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biogen Total Debt Analysis

Biogen's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
 2021 2022 2023 2024 (projected)
Gross Profit8.9B7.9B7.3B3.9B
Total Revenue11.0B10.2B9.8B10.3B

Total Debt

 = 

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current Biogen Total Debt

    
  7.34 B  
Most of Biogen's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biogen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Biogen Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Biogen is extremely important. It helps to project a fair market value of Biogen Stock properly, considering its historical fundamentals such as Total Debt. Since Biogen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biogen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biogen's interrelated accounts and indicators.
0.670.940.850.990.970.56-0.820.960.930.590.890.3-0.80.390.680.650.890.890.23-0.920.850.260.81-0.950.45-0.080.5-0.18-0.19-0.38
0.670.530.460.630.590.45-0.640.730.79-0.10.730.74-0.560.440.730.560.60.73-0.53-0.810.69-0.150.64-0.710.470.360.62-0.14-0.130.38
0.940.530.680.940.950.54-0.630.820.870.70.790.18-0.850.290.540.490.740.810.36-0.880.70.460.63-0.820.32-0.110.32-0.21-0.05-0.46
0.850.460.680.830.780.48-0.860.910.730.540.710.22-0.560.220.50.610.960.720.34-0.690.760.00.91-0.910.28-0.150.4-0.04-0.34-0.46
0.990.630.940.830.970.51-0.850.940.930.610.830.28-0.730.330.620.570.890.840.29-0.910.830.350.82-0.940.38-0.040.42-0.22-0.1-0.41
0.970.590.950.780.970.52-0.770.90.890.60.850.18-0.750.320.630.650.840.860.3-0.90.840.370.75-0.880.4-0.140.45-0.3-0.07-0.42
0.560.450.540.480.510.52-0.330.530.60.190.510.43-0.650.050.310.270.550.55-0.02-0.450.440.150.51-0.580.150.180.17-0.170.02-0.09
-0.82-0.64-0.63-0.86-0.85-0.77-0.33-0.9-0.81-0.32-0.71-0.370.37-0.33-0.62-0.58-0.91-0.71-0.090.76-0.85-0.1-0.920.9-0.4-0.08-0.490.180.150.22
0.960.730.820.910.940.90.53-0.90.910.440.890.37-0.690.440.740.730.940.870.11-0.880.90.090.9-0.980.51-0.050.6-0.14-0.28-0.28
0.930.790.870.730.930.890.6-0.810.910.350.850.53-0.760.330.620.510.860.850.01-0.920.820.30.82-0.940.350.220.41-0.350.05-0.13
0.59-0.10.70.540.610.60.19-0.320.440.350.32-0.35-0.53-0.080.090.180.460.340.84-0.440.250.360.31-0.450.01-0.45-0.080.11-0.24-0.82
0.890.730.790.710.830.850.51-0.710.890.850.320.25-0.710.50.740.810.750.880.0-0.850.860.120.7-0.840.52-0.140.61-0.27-0.21-0.2
0.30.740.180.220.280.180.43-0.370.370.53-0.350.25-0.360.290.39-0.010.360.39-0.64-0.420.3-0.170.45-0.460.170.770.3-0.010.10.58
-0.8-0.56-0.85-0.56-0.73-0.75-0.650.37-0.69-0.76-0.53-0.71-0.36-0.22-0.45-0.38-0.61-0.77-0.150.79-0.51-0.21-0.520.72-0.2-0.05-0.250.110.10.22
0.390.440.290.220.330.320.05-0.330.440.33-0.080.50.29-0.220.80.550.180.45-0.37-0.350.49-0.020.18-0.340.85-0.160.880.15-0.320.08
0.680.730.540.50.620.630.31-0.620.740.620.090.740.39-0.450.80.760.490.74-0.3-0.670.77-0.040.52-0.640.9-0.070.910.11-0.430.1
0.650.560.490.610.570.650.27-0.580.730.510.180.81-0.01-0.380.550.760.560.68-0.06-0.590.78-0.150.53-0.580.69-0.490.81-0.07-0.5-0.16
0.890.60.740.960.890.840.55-0.910.940.860.460.750.36-0.610.180.490.560.770.24-0.780.810.090.96-0.960.240.030.36-0.21-0.15-0.35
0.890.730.810.720.840.860.55-0.710.870.850.340.880.39-0.770.450.740.680.77-0.01-0.870.920.270.8-0.860.44-0.030.58-0.07-0.25-0.06
0.23-0.530.360.340.290.3-0.02-0.090.110.010.840.0-0.64-0.15-0.37-0.3-0.060.24-0.01-0.01-0.010.430.09-0.13-0.28-0.5-0.410.0-0.06-0.9
-0.92-0.81-0.88-0.69-0.91-0.9-0.450.76-0.88-0.92-0.44-0.85-0.420.79-0.35-0.67-0.59-0.78-0.87-0.01-0.8-0.2-0.760.87-0.36-0.09-0.480.170.130.11
0.850.690.70.760.830.840.44-0.850.90.820.250.860.3-0.510.490.770.780.810.92-0.01-0.80.250.86-0.850.53-0.10.66-0.14-0.26-0.09
0.26-0.150.460.00.350.370.15-0.10.090.30.360.12-0.17-0.21-0.02-0.04-0.150.090.270.43-0.20.250.1-0.14-0.10.0-0.21-0.210.34-0.29
0.810.640.630.910.820.750.51-0.920.90.820.310.70.45-0.520.180.520.530.960.80.09-0.760.860.1-0.930.230.120.39-0.12-0.19-0.13
-0.95-0.71-0.82-0.91-0.94-0.88-0.580.9-0.98-0.94-0.45-0.84-0.460.72-0.34-0.64-0.58-0.96-0.86-0.130.87-0.85-0.14-0.93-0.38-0.1-0.460.180.150.26
0.450.470.320.280.380.40.15-0.40.510.350.010.520.17-0.20.850.90.690.240.44-0.28-0.360.53-0.10.23-0.38-0.240.90.11-0.410.02
-0.080.36-0.11-0.15-0.04-0.140.18-0.08-0.050.22-0.45-0.140.77-0.05-0.16-0.07-0.490.03-0.03-0.5-0.09-0.10.00.12-0.1-0.24-0.25-0.140.440.59
0.50.620.320.40.420.450.17-0.490.60.41-0.080.610.3-0.250.880.910.810.360.58-0.41-0.480.66-0.210.39-0.460.9-0.250.14-0.480.13
-0.18-0.14-0.21-0.04-0.22-0.3-0.170.18-0.14-0.350.11-0.27-0.010.110.150.11-0.07-0.21-0.070.00.17-0.14-0.21-0.120.180.11-0.140.14-0.790.13
-0.19-0.13-0.05-0.34-0.1-0.070.020.15-0.280.05-0.24-0.210.10.1-0.32-0.43-0.5-0.15-0.25-0.060.13-0.260.34-0.190.15-0.410.44-0.48-0.790.08
-0.380.38-0.46-0.46-0.41-0.42-0.090.22-0.28-0.13-0.82-0.20.580.220.080.1-0.16-0.35-0.06-0.90.11-0.09-0.29-0.130.260.020.590.130.130.08
Click cells to compare fundamentals
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition

Biogen Short Long Term Debt Total

Short Long Term Debt Total

7.71 Billion

At present, Biogen's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
Based on the latest financial disclosure, Biogen Inc has a Total Debt of 7.34 B. This is 166.73% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 38.01% lower than that of the firm.

Biogen Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biogen's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biogen could also be used in its relative valuation, which is a method of valuing Biogen by comparing valuation metrics of similar companies.
Biogen is currently under evaluation in total debt category among related companies.

Biogen ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Biogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Biogen's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Biogen Institutional Holders

Institutional Holdings refers to the ownership stake in Biogen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Biogen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Biogen's value.
Shares
Morgan Stanley - Brokerage Accounts2023-12-31
1.6 M
Legal & General Group Plc2023-12-31
1.6 M
T. Rowe Price Associates, Inc.2023-12-31
1.5 M
Northern Trust Corp2023-12-31
1.5 M
Norges Bank2023-12-31
1.5 M
Dimensional Fund Advisors, Inc.2023-12-31
1.4 M
Van Eck Associates Corporation2023-12-31
1.4 M
Bank Of New York Mellon Corp2023-12-31
1.4 M
Pictet Asset Manangement Sa2023-12-31
1.3 M
Primecap Management Company2023-12-31
16.3 M
Vanguard Group Inc2023-12-31
14.4 M

Biogen Fundamentals

About Biogen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biogen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biogen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Total Debt To Capitalization 0.33  0.35 

Biogen Investors Sentiment

The influence of Biogen's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Biogen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Biogen's public news can be used to forecast risks associated with an investment in Biogen. The trend in average sentiment can be used to explain how an investor holding Biogen can time the market purely based on public headlines and social activities around Biogen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Biogen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Biogen's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Biogen's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Biogen.

Biogen Implied Volatility

    
  23.07  
Biogen's implied volatility exposes the market's sentiment of Biogen Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biogen's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biogen stock will not fluctuate a lot when Biogen's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biogen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biogen's short interest history, or implied volatility extrapolated from Biogen options trading.

Pair Trading with Biogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biogen Stock

  0.79MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Biogen Stock

  0.92EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.81MDWD Mediwound Downward RallyPairCorr
  0.78MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.56CLVRW Clever Leaves HoldingsPairCorr
  0.54MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.
The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out Biogen Piotroski F Score and Biogen Altman Z Score analysis.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stocks Directory
Find actively traded stocks across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.55)
Earnings Share
7.96
Revenue Per Share
67.972
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0458
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.